Cempra grosses $25mm via PIPE
Antibiotics developer Cempra Inc. has grossed $25.1mm through the private sale of 3.86mm common shares at $6.50 each (a 15% discount) to new and returning investors. Jefferies & Co., Cowen & Co., and Stifel Nicolaus & Co. were the placement agents.
- Large Molecule
- Private Investment in Public Equity
- Private Placement
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.